May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Naveen Pemmaraju: State-of-the-art review of BPDCN
Dec 10, 2024, 14:00

Naveen Pemmaraju: State-of-the-art review of BPDCN

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, posted the following on X:

“ASH24 Proud to share just out in ASH Hematology Education Program: BPDCN: State-of-the-art Review. Blood Journal.”

Naveen Pemmaraju: State-of-the-art review of BPDCN

Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.

His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.

More posts featuring Naveen Pemmaraju.